DCAT Value Chain Insights

COVID-19 and the Bio/Pharma Industry: The Bottom Line

What has been the impact of COVID-19 on bio/pharmaceutical companies’ bottom line? For companies successfully bringing products for COVID-19 to fruition, 1Q 2021 results have been positive. What is...

Into the Future: 3D Printing and Solid Dosage Drugs

Three-dimensional (3D) printing is an emerging technology across multiple industries, including the bio/pharmaceutical industry. To date, one drug using 3D printing has been approved by the FDA....

SPONSORED CONTENT

The Versatility and Value of Liquid-Filled Hard Capsules

Information
May 12, 2021
Sponsored by CapsCanada

While liquid-filled hard capsules (LFHCs) have been around for decades, today’s difficult APIs and increased competition have rekindled interest in this versatile and value-added dosage form. LFHCs’...

Read More
Continuous Manufacturing: An Efficient Way to Produce OSD Drugs

Information
April 28, 2021
Sponsored by Thermo Fisher Scientific

Continuous manufacturing is an innovative solution, providing flexibility and up to 1.65X scale-up cost savings compared to batch manufacturing.

Read More
A New Alliance: ICROM and PolyCrystalLine

Information
April 20, 2021
Sponsored by ICROM and PolyCrystalLine

ICROM and PolyCrystalLine SpA announce their strategic and exclusive partnership to provide integrated solutions for chemical development and custom manufacturing of APIs.

Read More